CA
NZ
UK
AU
IND
US
● Johnson & Johnson gained on Friday, closing at $261.44 and finishing among the Dow's advancers, with no fresh company news.
● Merck had no company-specific announcement and was lifted by a wave of buying across drugmakers and biotech companies.
● Moderna rocketed on Friday, closing at $225.00, up $28.00, at the top of its day's range of $197.17 to $225.00.
● Moderna climbed $28.00 to $225.00 on Friday, taking the stock to its highest level since 2021, according to market data.
● No company announcement explained the move.
● No company-specific news was found.
● No announcement, filing, analyst action, trial result or scheduled event from Novavax explained the move, according to one report.
● William Blair downgraded the stock to Market Perform.
● Doximity Ask led US-based models in the NOHARM benchmark.
● Elevance Health was among the managed-care stocks in focus on Friday after the 2027MedicareAdvantage Star Ratings were released.
Please wait processing your request...